Pediatric infection and sepsis in five age subgroups: single-center registry

Michael M Hermon1, Theresa Etmayr2, Jennifer Bettina Brandt3

  • 1Department of Pediatrics, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. michael.hermon@meduniwien.ac.at.

Insights

Pediatric sepsis and septic shock remain critical concerns. This study evaluated 201 pediatric intensive care patients, finding an 83% survival rate but lower survival for newborns and adolescents.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Epidemiology

Background:

  • Sepsis is a leading cause of death in children globally.
  • Despite improved treatments, pediatric sepsis incidence is rising.
  • Pediatric intensive care unit (PICU) patients are a vulnerable population.

Purpose of the Study:

  • To evaluate the clinical course of sepsis in pediatric intensive care patients.
  • To analyze sepsis and septic shock incidence and outcomes in a PICU cohort.
  • To identify risk factors and survival rates across different pediatric age groups.

Main Methods:

  • Retrospective data analysis of 201 pediatric patients diagnosed with infection or sepsis between 2005 and 2015.
  • Patients were categorized into five age subgroups.
  • Evaluation of demographic, clinical, and outcome data.

Main Results:

  • The majority of patients were newborns, infants, and toddlers.
  • 40% of patients had sepsis, and 6% had septic shock.
  • Viral infections were most common (59%), with an overall survival rate of 83%. Newborns and adolescents had the lowest survival rates.

Conclusions:

  • Findings align with existing literature on pediatric sepsis management.
  • Optimal sepsis care includes prompt broad-spectrum antibiotics, fluid resuscitation, and source control.
  • Strict hygiene and adherence to evidence-based treatment protocols are crucial for improving outcomes in pediatric sepsis.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
151
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
124
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
101
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
132
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K